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Spatial sequestration and oligomer remodeling during
de novo [PSIC] formation
Douglas R. Lyke and Anita L. Manogaran
Department of Biological Sciences, Marquette University, Milwaukee, WI, USA

ABSTRACT. Prions are misfolded, aggregated, infectious proteins found in a range of organisms from
mammals to bacteria. In mammals, prion formation is difficult to study because misfolding and
aggregation take place prior to symptom presentation. The study of the yeast prion [PSIC], which is the
misfolded infectious form of Sup35p, provides a tractable system to monitor prion formation in real
time. Recently, we showed that the de novo formation of prion aggregates begins with the appearance
of highly mobile cytoplasmic foci, called early foci, which assemble into larger ring or dot structures.
We also observed SDS-resistant oligomers during formation, and lysates containing newly formed
oligomers can convert [psi¡] cells to the [PSIC] state, suggesting that these oligomers have infectious
potential. Here, we further characterize two aspects of prion formation: spatial sequestration of early
foci and oligomerization of endogenous Sup35p. Our data provides important insights into the process
of prion formation and explores the minimal oligomer requirement for infectivity.
KEYWORDS. [PSIC], amyloid, infectivity, inheritance, oligomer, prion, spatial sequestration,
Sup35, yeast

INTRODUCTION
Prion formation involves the spontaneous
conversion of native monomeric protein into
misfolded infectious conformers. In mammalian
systems, conversion events occur well before
the presentation of symptoms, making study of

these initial formation events extremely challenging. Several groups have used in vitro strategies and chemical manipulations to induce
misfolding, which has provided some important
insights into prion conversion (reviewed in
ref.1). Yet, there is still much left unanswered
about how conversion leads to infectivity.
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Yeast prions have contributed immensely to
our overall understanding of prion formation.
Yeast prions share many characteristics with
mammalian prions such as exhibiting detergent
resistance, existing as strains or variants,2 spontaneously forming at very low frequencies
within the population,3-5 and being infectious.6,7 The ability to increase rates of prion
formation in yeast through “prion induction”
provides a tractable means to study the formation process in vivo. The prion induction process involves the overexpression of a prion
protein, which is thought to increase the chance
of a misfolding event.8 De novo formation is
further increased by the presence of a second
prion, which likely allows for heterologous
cross-seeding.9-11
The understanding of prion formation has
been facilitated by the study of [PSIC], the
prion form of the Sup35 protein. De novo
[PSIC] formation can be monitored microscopically by fusing full-length Sup35p or
it’s prion domain (the N-terminus and middle domain of Sup35p; PrD) to a green fluorescent protein (Sup35PrD-GFP).12 The
initial steps of prion induction have been
shown to involve the assembly of Sup35PrDGFP into large fluorescent ring and dot-like
aggregates.12 These fluorescent aggregates
are hallmarks of prion formation since cells
containing these aggregates can result in a
proportion of their progeny that are [PSIC],
whereas cells lacking these aggregates
remain [psi¡].13 However, the process in
which these aggregates form and the biochemical changes that occur over time to
produce an infectious conformer is unclear.
Our recent work has provided insight into
some of these unanswered questions. Using 3D
time-lapse microscopy, we were able to capture
the in vivo assembly of Sup35PrD-GFP ring
and dot structures in real time. We observed
that the formation process starts with one or
several small fluorescent foci (which we term
“early foci”). These early foci tend to coalesce
into a larger aggregate that grows into a ring or
dot shaped structure. We analyzed over 90 cells
undergoing prion induction and found that
there appeared to be no obvious preference for
early foci to assemble into ring or dot
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structures, although cells containing either
structure were able to give rise to [PSIC]
colonies.14
We next asked how the Sup35PrD-GFP
assembles into a prion oligomer during formation. Biochemical analysis of cell cultures
taken at sequential time points in the aggregate formation process showed that the
Sup35PrD-GFP protein formed SDS-resistant
oligomers that change in size over time. For
example, we observed a SDS-resistant high
molecular weight band as early as 8 hours of
induction, well before the first microscopic
visualization of Sup35PrD-GFP early foci. By
24 hours, we observed distinct changes in the
migration of the oligomer shifting from a single band to a large smear. Our data suggest
that the Sup35PrD-GFP oligomer assembles
into a diverse population of sizes during prion
formation. In contrast, we noticed that endogenous Sup35p oligomers were only detectable
at 24 hours, and had a slower migration compared to those that are oligomers associated
with propagating [PSIC] cultures.14 It can be
envisioned that the endogenous Sup35p oligomer must undergo remodeling over time to
become [PSIC].
We also asked when do prions gain their
infectious nature. To begin to answer this question, cell lysates obtained from cultures at different times of the induction process were
transfected into [psi¡] strains. We previously
observed that lysates from cultures containing
newly formed ring and dot structures were able
to convert [psi¡] recipient strains to [PSIC].14
Our data suggest that the infectious nature of
the prion is not limited to the [PSIC] state, but
appears to be acquired early during prion
formation.

EARLY FOCI AND SPATIAL
SEQUESTRATION
The age of the mother may influence how
early foci form. We previously observed that
early foci initially appear in G2/M phase cells.
Interestingly, early foci rarely appeared in the
daughter bud by herself, but rather in the
mother alone or simultaneously in the mother
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cell and daughter bud.14 In young mothers, it
has been shown that damaged proteins or
unhealthy organelles are sequestered in the
mother cell, leaving the daughter bud rejuvenated and free of potentially harmful material.15 In contrast, damaged or aggregation
prone proteins are passed to daughter buds
more frequently in mutants with a shortened
life span.16,17 Therefore, it is possible that the
age of the mother may correlate with the ability
to form early foci in the daughter bud.

To explore how early foci are sequestered in
the mother cell and daughter bud, we reanalyzed our 3D time-lapse microscopy videos.
We observed that early foci behavior was different in the daughter bud compared to the corresponding mother cell. We analyzed 22 G2/M
cells where early foci were present in both the
mother cell and daughter bud. We found that
early foci quickly coalesced into one single
aggregate in the daughter bud, but remained as
separate aggregates in the mother cell (Fig. 1A

FIGURE 1. Protein aggregates coalesce in daughter buds but not in mother cells. A. Sup35PrDGFP was overexpressed for approximately 18 hours, and then placed on 8-well glass bottom slides
and imaged for an additional 12 hours according to Sharma et al. (2017).14 Of the 1382 cells that
were imaged, 20.8% contained ring or line aggregates. Of these cells with aggregates, the initial
formation of early foci was captured in 22 G2/M phase cells that contained early foci in both mother
cell and daughter bud. These cells were followed until larger aggregates were assembled. Representative images of early foci initially appearing in both mother cell and daughter bud
(01:00 minute) to their fusion in the daughter bud (04:00 minute) are shown. Yellow and green
arrows point to the early foci in the mother cell, while the red and blue arrows are in the daughter
bud, turning grey when they merge. B. Early foci trajectories (from part A) followed for 16 minutes
are shown. The movement of each foci was tracked on a 2D plane, with colors corresponding to
arrows in part A in the mother (left cell) and daughter bud (right cell). C. 22 time-lapse videos were
analyzed for the number of aggregates in the mother cell and daughter bud present at the end of
recordings, most of which ranged from one to six hours. The box-plot represents the mean (middle
line), upper and lower quartiles and outliers (open circle). Statistically significant differences in
aggregate formation in the mother cell and daughter bud were determined by a paired two-tailed
t-test (p<0.0001).
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and B). The single aggregate in the daughter
bud and the multiple distinct aggregates in the
mother cell were maintained until the end of
the time-lapse recordings, which went up to
6 hours. Quantification of early foci in mother
cells and daughter buds at the end of the timelapse recordings showed that mother cells had
on average 2 aggregates versus the daughter
that consistently had one (Fig. 1C). It is possible that age may play a role in the inability to
fuse early foci into one central aggregate in the
mother cell. Recently, Kumar et al.18 showed
that actin/myosin mediated networks are used
to move aggregates into a cellular inclusion
called IPOD, Insoluble PrOtein Deposit. It is
possible the rejuvenated daughter bud has
robust actin/myosin networks to efficiently coalesce foci into IPOD but the mother cell does
not. Since multiple aggregates were observed
in the mother cell, it is possible that aggregates
in aged cells are not held exclusively at IPOD.
Recent evidence suggests that there are other
protein accumulation sites in aged cells. For
example, propagating [PSIC] aggregates in
aged cells accumulate in a deposit called
APOD,19 whereas protein accumulation on the
surface of the ER increases with age.20 Further
work with early foci will be required to understand the differences between how aggregates
are sequestered in mother cells and daughter
buds.

THE FORMATION OF ENDOGENOUS
SUP35P OLIGOMERS DURING DE
NOVO PRION FORMATION AND THE
POTENTIAL FOR INFECTIVITY
We recently observed that Sup35PrD-GFP
forms SDS-resistant oligomers that change in
size over time using Semi-Denaturing Detergent
Agarose Gel Electrophoresis (SDD-AGE21)
methods, yet the ability to resolve the endogenous Sup35p was more difficult.14 To better
resolve endogenous Sup35p oligomerization during prion induction, we performed sedimentation
analysis on induced cultures at incremental time
points using sucrose gradient centrifugation. We
found that as early as 8 hours of induction,
Sup35p sediments to heavier fractions compared
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to uninduced and [psi¡] controls (Fig. 2). Our
data provides additional support that Sup35p
forms complexes well before the formation of
visible Sup35PrD-GFP aggregates. By 24 hours,
the relative distribution of Sup35p shifts from
lighter to heavier fractions. The change in sedimentation suggests that the endogenous Sup35p
likely forms complexes that are remodeling to
form a propagating prion in vivo.
It is unclear when a prion gains its infectious quality. Previous work showed that
recombinant derived Sup35p fibrils were
able to convert [psi¡] cells to [PSIC] cells,
providing solid proof for the protein only
hypothesis of prion infection.6,7 We recently
asked at what point in the induction process
would lysates contain infectious material.
Surprisingly, we found that infectivity was
observed from lysates generated from cultures induced for little as 16 hours, yet
lysates from prior time points were not
infectious. Since we observe a change in
Sup35p sedimentation between 8 and
16 hours, it is possible that there is a transition state in which immature oligomers go
FIGURE 2. Endogenous Sup35p sediments in
heavy fractions by 24 hours of induction.
Sup35PrD-GFP was overexpressed for 8, 16,
and 24 hours. Cultures were lysed using glass
beads and protein was immediately separated
by sucrose gradient centrifugation (20-60%
sucrose). Samples were centrifuged at 4 C for
1 hour. Seven fractions were collected and run
on SDS-PAGE for immunoblotting. AntiSup35C antibody was used in immunoblot analysis. An uninduced 24 hour culture, [PSIC] and
[psi¡] culture were also used as controls.
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from a non-infectious form to a mature
infectious form. Conversely, it could be
argued that the oligomer must reach a critical concentration for infectivity, implying
that the initially formed oligomer has inherent infectious qualities. Regardless of the
explanation, prion formation in yeast will
continue to provide valuable insights into
how and when a newly formed prion
becomes infectious.
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